Assignee
RHIZEN PHARMACEUTICALS AG
CH·1 granted patent·6 pending applications·0 citations·filing 2019–2025
Top patents by PatentIndex Score
7 records- 0181US2024360095A1Novel kinase modulatorsRHIZEN PHARMACEUTICALS AG·Filed 2023·Application pending·0 cites
- 0263US2026062415A1Purine derivatives as sik-3 inhibitorsRHIZEN PHARMACEUTICALS AG·Filed 2025·Application pending·0 cites
- 0357US12428422B2Purine derivatives as SIK-3 inhibitorsRHIZEN PHARMACEUTICALS AG·Filed 2021·Granted Sep 30, 2025·0 cites·6 claims
- 0454US2024199582A1Inhibitors of poly(adp-ribose) polymeraseRHIZEN PHARMACEUTICALS AG·Filed 2022·Application pending·0 cites
- 0548US2023234938A1Novel compounds useful as poly(adp-ribose) polymerase (parp) inhibitorsRHIZEN PHARMACEUTICALS AG·Filed 2021·Application pending·0 cites
- 0648US2022387362A1Compositions comprising a dhodh inhibitor for the treatment of acute myeloid leukemiaRHIZEN PHARMACEUTICALS AG·Filed 2020·Application pending·0 cites
- 0748US2022040162A1Compositions comprising a crac inhibitor and a corticosteroid and methods of use thereofRHIZEN PHARMACEUTICALS AG·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →